Laser Announces New Orders
Laser Photonics Corporation (NASDAQ: LASE), a leading global developer of industrial laser systems for cleaning and other material processing applications, today announced its Control Micro Systems (CMS) subsidiary has received multiple follow on orders for its advanced laser systems.John Armstrong, Executive Vice President of LPC, commented: “These orders for additional CMS laser systems across multiple industries demonstrate both the high levels of customer satisfaction CMS is bringing to the market and the growing market demand for advanced laser equipment across various verticals. These two factors point towards continued success for this recently acquired business.”The first order is for CMS’s UV Laser Drilling System, a cutting-edge solution designed for high-precision applications. This automated, water-cooled system leverages a state-of-the-art ultraviolet laser and an integrated through-the-optics vision system, enabling accurate positioning for precise hole drilling. The client, a leading pharmaceutical company, has consistently relied on CMS’s expertise, placing multiple orders over the years.The second order is for the PCB Laser Marking Workstation, which is tailored for marking printed circuit boards. This system, powered by an air-cooled CO2 laser, supports various PCB sizes and circuit arrays, offering custom conveyor configurations for seamless integration into assembly lines. Its sophisticated vision system ensures tight-tolerance alignment and code verification, making it a critical tool for efficient, high-quality production.LASE shares closed Thursday at $5.30.
Recent Posts

Romanian Inflation Ends Tumultuous Year in Politics Close to 10%

UK Boosts Support For Offshore Wind in Bumper Auction

Ireland Is Trying to Get Back on the Data Center Bandwagon

Notice Concerning Change of Representative Executive Officer

Polish Recycler Bets Millions on Europe’s Critical Metals Push

Blistering Metals Rally Sends Silver, Tin and Copper to Records

Wellington Management Appoints Alex Behm to Strengthen Secondaries Capabilities

TCS and AMD Announce Strategic Collaboration to Drive AI Adoption at Scale

New data reinforces Ipsen’s commitment to bringing solutions and addressing care gaps in neurological diseases at TOXINS

TOXINS 2026: Clinical Updates on Galderma’s Leading Neuromodulator Portfolio Further Reinforce Its Leadership in Injectable Aesthetics


